# clm_3319A0215022

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 2,158,000,000 United States dollar  
valid_from: 2011-03-31  
valid_to: 2011-06-30  
published: 2011-05-09  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1C2CAA0EE3AB  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 2,158,000,000 United States dollar", as of 2011-03-31 (until 2011-06-30). Claim clm_3319A0215022, https://asof.is/claim/clm_3319A0215022, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2011, filed 2011-05-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000095012311047041/0000950123-11-047041-index.htm (primary, SEC EDGAR 10-Q Q1 FY2011, published 2011-05-09)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 2,296,400,000 United States dollar | valid 2010-09-30 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_3319A0215022](/claim/clm_3319A0215022.md) | [clm_CB134DA21407](/claim/clm_CB134DA21407.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.